STA
INSM icon

Summit Trail Advisors’s Insmed INSM Stock Holding History

Summit Trail Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$845K Buy
7,922
+1,208
+18% +$146K 0.01% 1050
2026
Q1 		$1.1M Buy
6,714
+2,250
+50% +$346K 0.02% 895
2025
Q4 		$777K Buy
4,464
+2,731
+158% +$498K 0.01% 933
2025
Q3 		$250K Buy
+1,733
New +$212K ﹤0.01% 1246
2018
Q2 		– Sell
-12,178
Closed -$250K – 556
2018
Q1 		$250K Buy
+12,178
New +$320K 0.04% 319

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Summit Trail Advisors's INSM Position: Q2 2026 in Review

Summit Trail Advisors increased its Insmed (INSM) stake by 18% in Q2 2026, buying an estimated $146K and bringing the position to 7,922 shares worth $845K. The position accounts for 0.01% of the portfolio, ranked #1050.

Summit Trail Advisors first reported a position in INSM in Q1 2018 and has held it in 5 quarters since. The position peaked at $1.1M in Q1 2026. 664 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Summit Trail Advisors held 7,922 shares of Insmed worth $845K as of Q2 2026.
  • Summit Trail Advisors bought 1,208 Insmed shares in Q2 2026, an estimated $146K.
  • Insmed made up 0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #1050 holding.
  • Summit Trail Advisors first reported a position in Insmed in Q1 2018 and has held it in 5 quarters since.
  • Summit Trail Advisors's Insmed position peaked at $1.1M in Q1 2026.
  • 664 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.